Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP TMS SA to Report First Quarter 2017 Financial Results on May 17, 2017
LYON, France , May 2, 2017 - EDAP TMS SA (NASDAQ: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the first quarter ended March 31, 2017 , after the close of the financial markets on May 17, 2017 .
View HTML
Toggle Summary EDAP TMS SA to Report Fourth Quarter and Full Year 2016 Results on April 3, 2017
EDAP TMS SA to Report Fourth Quarter and Full Year 2016 Results on April 3, 2017 LYON, France , March 14, 2017 - EDAP TMS SA (NASDAQ: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the fourth quarter and year ended December 31,
View HTML
Toggle Summary EDAP TMS to Announce Third Quarter 2017 Financial Results on Wednesday, November 15, 2017
Contact: Blandine Confort Investor Relations / Legal Affairs EDAP TMS SA +33 4 72 15 31 72 bconfort@edap-tms.com Investors: Rich Cockrell CG CAPITAL 877.889.1972 rich@cg.capital   Conference Call to Review Results to be Held Thursday, November 16, 2017 LYON, France , November 01, 2017 - EDAP TMS SA
View HTML
Toggle Summary EDAP TMS to Present at Rodman and Renshaw Global Investment Conference
LYON, France , Sept. 2, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that Marc Oczachowski , Chief Executive Officer of EDAP TMS is scheduled to present at the 17 th Annual Rodman & Renshaw Global Investment conference being held
View HTML
Toggle Summary EDAP TMS to Present at the 18th Annual Rodman and Renshaw Global Investment Conference
LYON, France , Sept. 06, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA  (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that Marc Oczachowski , Chief Executive Officer of EDAP TMS , is scheduled to present at the 18 th Annual Rodman & Renshaw Global Investment Conference being
View HTML
Toggle Summary EDAP TMS to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
LYON, France , August 24, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that Marc Oczachowski , Chief Executive Officer, will present at the 19 th Annual Rodman & Renshaw Global Investment Conference to be held September 10-12, 2017
View HTML
Toggle Summary Edap Tms: EDAP Announces Positive Outcome from CPT Panel for HIFU Reimbursement in the U.S.
AMA allocates a new Category 1 CPT code for High Intensity Focused Ultrasound (HIFU)   Definitive CPT code will cover the transrectal ablation of malignant prostate tissue with HIFU including ultrasound guidance LYON, France , June 10, 2019 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”) , the global
View HTML
Toggle Summary EDAP to Add University of Colorado Under Direction of Dr. David Crawford to Clinical Study
EDAP to Add University of Colorado Under Direction of Dr. David Crawford to Clinical Study LYON, France , June 5 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, intends to add the University of
View HTML
Toggle Summary EDAP to Announce First Quarter 2023 Financial Results on May 17, 2023  
- Company to host conference call and webcast on Wednesday, May 1 7 th at 8:30 am EDT - LYON, France, May 3, 2023 - EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the first quarter ended
View HTML
Toggle Summary EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024
Company to host conference call and webcast on Thursday, May 16 th at 8:30am EDT LYON, France, May 2, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the first quarter ended March
View HTML